Extragenital Mycoplasma hominis Infection in Two Liver
. CT scan demonstrates liver abscess formation (arrow) due to Mycoplasma hominis in a 29-year-old liver transplant recipient.
M hominis as well as coagulase-negative staphylococci and Enterococcus faecium were isolated from the swabs. Since the tuf gene was amplified from suspicious primary colonies and since subsequent sequence determination allowed M hominis to be identified within 24 hours, treatment with ciprofloxacin [8, 9] was started immediately and continued for 12 days. Ciprofloxacin was administered with vancomycin for treatment of infection due to gram-positive cocci.
Despite initial improvement in the patient's condition, a CT scan revealed a subcapsular mass of the sixth hepatic segment 15 days after completion of the course of ciprofloxacin therapy (figure 1). Drainage of the abscess yielded 25 mL of pus. Bacteriologic analysis of the aspirate by initial plating on mycoplasma agar and sequencing of the tuf gene PCR product from suspicious colonies revealed intrahepatic M hominis abscess formation. Aerobic and anaerobic culture of the abscess did not yield any other bacteria. The patient was then successfully treated with combination antibiotic therapy that included clindamycin and doxycycline [10] for 18 days and by irrigation of the abscess with sodium chloride solution for 10 days. She was discharged to her home 5 weeks after completion of the combination therapy, and a control CT scan was not performed.
Since there are only a few reports on extragenital M hominis infections in liver transplant recipients, our two cases serve to emphasize the pathogenic potential of M hominis for these patients. Bacteriological laboratories that perform tests for liver transplant recipients should include mycoplasma agar in their routine diagnostic program to accelerate the diagnosis of M. hominis infection. Tuf gene amplification [5] [6] [7] directly from suspicious colonies followed by sequence determination of the PCR product allows diagnosis of the species within 24 hours and provides the diagnostic basis for rapid specific antibiotic therapy. Despite initial therapy with ciprofloxacin, a liver abscess developed in one patient; this abscess was then successfully treated by drainage and irrigation and with systemic antibiotic therapy (i.e., clindamycin combined with doxycycline). Active tuberculosis in patients with prior tuberculous infection can occur after endogenous reactivation or exogenous reinfection. Endogenous reactivation results from reactivation of viable tubercle bacilli in dormant foci that persist after primary infection. Exogenous reinfection results from inhalation of new bacilli, causing active disease. Since the publication of Stead's article in 1967 [1] , exogenous reinfection has not been considered a significant cause of tuberculosis in individuals known to have had previous tuberculin reaction in the United States and other developed countries.
However, recent reports from the United States have documented exogenous reinfection with resistant Mycobacterium tuberculosis in patients with advanced HIV infection, alcoholism, and malnutrition [2] [3] [4] [5] . We describe a diabetic patient with a history of tuberculosis who is receiving treatment for multidrug-resistant tuberculosis (MDRTB) apparently acquired through exogenous reinfection.
A 60-year-old Peruvian man was treated for pulmonary tuberculosis in 1951 with collapse therapy and intramuscular streptomycin. He moved to New York in 1953 and has worked in our hospital's housekeeping department since 1971. In 1974, he underwent a tine test done at the employee health service, which was positive. Other than adult-onset diabetes mellitus, well controlled with oral hypoglycemic agents, he had no other illnesses and took no other medications.
The patient was well until September 1994, when he developed a persistent productive cough and lost 20 pounds over the ensuing 2 months. In November 1994 a chest radiograph revealed patchy nodular infiltrates of the right lung and left-sided pleural thickening. No previous radiograph was available for review. He denied all risk factors for HIV infection and tested negative for antibodies to the virus. Multiple sputum specimens were smear positive for acid-fast bacilli, and cultures yielded M tuberculosis that was resistant to seven antituberculous drugs, including all five first-line agents. Restriction fragment length polymorphism (RFLP) analysis revealed that this strain's pattern was identical to that of a strain responsible for many MDRTB cases in New York City (Public Health Research Institute Tuberculosis Center [New York City] strain W) [6] .
In January 1997 the patient was completing his 24th month of directly observed therapy, which consisted of daily oral ofloxacin, cycloserine, p-aminosalicylic acid, and pyridoxine; intramuscular capreomycin was included in this regimen during the first 6 months. His compliance with this regimen has exceeded 90%. After he started receiving this therapy, his sputum smears and cultures converted to negative within 2 months, and he had an excellent clinical and radiographic response.
The findings in this case illustrate probable exogenous reinfection of a diabetic man with MDRTB. Despite lack of culture confirmation of our patient's original episode of tuberculosis, much evidence supports prior infection, including his description of a clinical picture consistent with tuberculosis, previous surgical and medical treatment for tuberculosis, and a positive tine test in 1974. In 1994 he had culture-confirmed tuberculosis, probably caused by a strain of M. tuberculosis different from that which caused his initial infection. His job involved cleaning respiratory isolation rooms of patients with suspected and known tuberculosis, including some patients with MDRTB whose isolates had a strain W pattern. Strain W, which apparently dates back to the 1980s, has been recovered primarily in New York City and has caused many cases of MDRTB, including nosocomial outbreaks [6] . This strain first appeared at our institution in November 1992. The RFLP pattern of the isolate from the patient described herein matched the pattern of isolates from other patients seen at our hospital.
This case, as well as those previously reported [2] [3] [4] [5] , demonstrates that prior tuberculous infection or disease does not provide all patients with adequate protective immunity to reinfection with a different strain of M. tuberculosis. These patients were all in groups considered to be at high risk of developing active disease after tuberculous infection [7] . The factors that make such patients more likely to develop disease when they are infected may also put them at greater risk of reinfection when exposed again to M tuberculosis.
Exogenous reinfection is believed to be a significant cause of tuberculosis in developing countries and other areas where
